Morishita Jintan Co., Ltd. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Morishita Jintan Co., Ltd. with three other
companies in this sector in Japan:
Sosei Group Corporation
sales of 8.15 billion Japanese Yen [US$70.59 million]
of which 98%
was Overseas Pharmaceutical Business),
Shin Nippon Biomedical Laboratories Ltd
(14.75 billion Japanese Yen [US$127.74 million]
of which 80%
was Pre-Clinical Business), and
Linical Company Limited
(7.67 billion Japanese Yen [US$66.39 million]
of which 93%
was Cro Business).
Morishita Jintan Co., Ltd. reported sales of ¥10.43 billion (US$90.34 million)
March of 2016.
increase of 6.3%
versus 2015, when the company's sales were ¥9.82 billion.
Sales of Capsule Contract Business saw an increase
10.3% in 2016, from
¥3.44 billion to ¥3.80 billion.
Not all segments of Morishita Jintan Co., Ltd. experienced an increase in sales in 2016:
sales of Other fell 51.7% to ¥14.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).